In the present study, though PD-L1 tumor cell expression had no prognostic significance, immune cell expression of PD-L1 was associated with poor outcome in the pSTAT3-negative R-CHOP-treated subset in univariate analysis. This evidence concerns the gene CD274 and neoplasm.